Beyond the MEK-pocket: Can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK?
Journal Article
·
· Bioorg. Med. Chem. Lett.
- Pfizer
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- INDUSTRY
- OSTI ID:
- 1107398
- Journal Information:
- Bioorg. Med. Chem. Lett., Vol. 19, Issue (1) ; 01, 2009
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Beyond the MEK-pocket: Can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK?
Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region
Journal Article
·
Thu Sep 02 00:00:00 EDT 2010
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1107398
+12 more
Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479
Journal Article
·
Wed Oct 01 00:00:00 EDT 2014
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1107398
+14 more
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region
Journal Article
·
Fri Jan 20 00:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1107398
+17 more